Free Trial

Merck KGaA (OTCMKTS:MKGAF) Shares Gap Up - Should You Buy?

Merck KGaA logo with Medical background

Merck KGaA (OTCMKTS:MKGAF - Get Free Report)'s stock price gapped up before the market opened on Monday . The stock had previously closed at $124.46, but opened at $129.14. Merck KGaA shares last traded at $129.14, with a volume of 64 shares changing hands.

Merck KGaA Stock Up 2.8%

The company has a market cap of $16.99 billion, a P/E ratio of 20.07 and a beta of 0.96. The company's 50-day moving average is $134.28 and its two-hundred day moving average is $140.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines